Jeffrey Perl

MD, FRCP(C), SM

Associate Scientist, Li Ka Shing Knowledge Institute

Biography

Dr. Jeffrey Perl received his MD from the University of Toronto in 2003, where he also completed his post-graduate training in both Internal Medicine and Nephrology in 2008. In 2010, he completed his Masters of Science in Clinical Epidemiology from The Harvard School of Public Health.

Dr. Perl is currently a Staff Nephrologist at St Michael’s Hospital in Toronto and an Assistant Professor in the Department of Medicine at the University of Toronto. He currently chairs the International Society of Nephrology’s Young Nephrologists Committee. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on peritoneal dialysis. Dr. Perl is a primary investigator in The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Recent Publications

  1. Al Sahlawi, M, Liew, A, Perl, J. Cefepime as Empirical Peritoneal Dialysis-Associated Peritonitis Treatment: Something to Dwell On?. Am. J. Kidney Dis. 2019; :. doi: 10.1053/j.ajkd.2019.06.008. PubMed PMID:31515138 .
  2. Rope, R, Perl, J, Anand, S, International Society of Nephrology North American and Caribbean Regional Board. Global Health Training Opportunities in North American Nephrology Fellowships. Kidney Int Rep. 2019;4 (7):904-907. doi: 10.1016/j.ekir.2019.04.019. PubMed PMID:31384697 PubMed Central PMC6662156.
  3. Trinh, E, Hanley, JA, Nadeau-Fredette, AC, Perl, J, Chan, CT. A comparison of technique survival in Canadian peritoneal dialysis and home hemodialysis patients. Nephrol. Dial. Transplant. 2019; :. doi: 10.1093/ndt/gfz075. PubMed PMID:31329952 .
  4. Vinson, AJ, Perl, J, Tennankore, KK. Survival Comparisons of Home Dialysis Versus In-Center Hemodialysis: A Narrative Review. Can J Kidney Health Dis. 2019;6 :2054358119861941. doi: 10.1177/2054358119861941. PubMed PMID:31321065 PubMed Central PMC6628511.
  5. Shen, JI, Erickson, KF, Chen, L, Vangala, S, Leng, L, Shah, A et al.. Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States. Clin J Am Soc Nephrol. 2019;14 (8):1200-1212. doi: 10.2215/CJN.00290119. PubMed PMID:31320318 PubMed Central PMC6682814.
  6. Shen, JI, Schreiber, MJ, Zhao, J, Robinson, BM, Pisoni, RL, Mehrotra, R et al.. Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir?. Clin J Am Soc Nephrol. 2019;14 (7):1067-1070. doi: 10.2215/CJN.01320119. PubMed PMID:31278114 PubMed Central PMC6625627.
  7. Manera, KE, Tong, A, Craig, JC, Shen, J, Jesudason, S, Cho, Y et al.. An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis. Kidney Int. 2019;96 (3):699-710. doi: 10.1016/j.kint.2019.03.015. PubMed PMID:31200941 .
  8. Glavinovic, T, Kashani, M, Al-Sahlawi, M, Anderson, E, Freeman, M, Dacouris, N et al.. A Peritoneal Dialysis Access Quality Improvement Initiative: A Single-Center Experience. Perit Dial Int. ;39 (5):437-446. doi: 10.3747/pdi.2018.00233. PubMed PMID:31123070 .
  9. Hecking, M, McCullough, KP, Port, FK, Bieber, B, Morgenstern, H, Yamamoto, H et al.. Self-reported Urine Volume in Hemodialysis Patients: Predictors and Mortality Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 2019;74 (3):425-428. doi: 10.1053/j.ajkd.2019.02.012. PubMed PMID:31005373 .
  10. Sukul, N, Zhao, J, Fuller, DS, Karaboyas, A, Bieber, B, Sloand, JA et al.. Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS. BMC Nephrol. 2019;20 (1):116. doi: 10.1186/s12882-019-1304-3. PubMed PMID:30940103 PubMed Central PMC6446371.
Search PubMed

Affiliations & Other Activities

  • Nephrologist, Division of Nephrology, St. Michael’s Hospital
  • Assistant Professor of Medicine, University of Toronto
  • Chair, International Society of Nephrology’s Young Nephrologists Committee
X